Cardoen Pharma SRL
0.1 FTECardoen Pharma reported total assets of €1.79m at the end of the 2025 financial year (annual accounts filed with the NBB on 28 May 2026), with 0.1 full-time equivalent.
The score of Cardoen Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -32 % Total assets +62 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Cardoen Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 May 2026
- Year ended 31 Dec 2024filed on 04 Jul 2025
- Year ended 31 Dec 2023filed on 10 Jun 2024
- Year ended 31 Dec 2022filed on 26 May 2023
- Year ended 31 Dec 2021filed on 23 May 2022
Cardoen Pharma's financial analysis
- Solvency35.0%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Cardoen Pharma
Cardoen Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0422.123.016
- VAT number
- BE0422123016
- Peppol
- Registered · 0208:0422123016 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Nov 1981
- Registered office
- 8750 Wingene
- Size
- Micro · 0.1 FTE
- Latest accounts
- 2025 · filed on 28 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Cardoen Pharma (SRL) has been based in Wingene since 1981, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 36,442 € and equity of 628,114 €; its revenue is not published. With 0.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 35.0%, below the median of its sector (44.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Cardoen Pharma
Companies in the same business, of comparable size and area, outside its group.
- Antoine Pharma Retail sale of pharmaceutical products Ixelles · balance sheet €1.46m
- Pharmakes Retail sale of pharmaceutical products Ypres · balance sheet €1.57m
- Duchi-Naert Retail sale of pharmaceutical products Harelbeke · balance sheet €1.52m
- Strybol Iben Pharma Retail sale of pharmaceutical products Maldegem · balance sheet €2.18m
- Apotheek De Boeck Retail sale of pharmaceutical products Lierde · balance sheet €1.30m
- PiotFarma Retail sale of pharmaceutical products Tielt-Winge · balance sheet €1.79m
- geroFarma Retail sale of pharmaceutical products Kortrijk · balance sheet €1.05m
- Apkpharma Retail sale of pharmaceutical products Manage · balance sheet €1.05m
Frequently asked questions about Cardoen Pharma
What is the revenue of Cardoen Pharma?
Cardoen Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Cardoen Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0422123016 for Cardoen Pharma, if the company is VAT-registered. Its company number (CBE) is 0422.123.016.
Where is the registered office of Cardoen Pharma?
According to the CBE register, the registered office of Cardoen Pharma is in 8750 Wingene.
What is the equity of Cardoen Pharma?
At the close of the 2025 financial year, the equity of Cardoen Pharma amounts to 628,114 €, a solvency of 35.0% of total assets.
How many people work at Cardoen Pharma?
0.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Cardoen Pharma?
The register lists 1 active mandates at Cardoen Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Cardoen Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →